Galectin Therapeutics Inc (GALT)
2.78
+0.06
(+2.21%)
USD |
NASDAQ |
Nov 22, 16:00
2.77
-0.01
(-0.36%)
After-Hours: 20:00
Galectin Therapeutics Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2015 | 0.00 |
| September 30, 2015 | |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | -0.40M |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.056M |
| September 30, 2012 | 0.008M |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | -0.005M |
| September 30, 2011 | -0.005M |
| June 30, 2011 | -0.005M |
| March 31, 2011 | 0.00 |
| December 31, 2010 | 0.00 |
| September 30, 2010 | 0.00 |
| June 30, 2010 | 0.00 |
| March 31, 2010 | |
| December 31, 2009 |
| Date | Value |
|---|---|
| September 30, 2009 | |
| June 30, 2009 | |
| March 31, 2009 | |
| December 31, 2008 | 0.003M |
| September 30, 2008 | 0.005M |
| June 30, 2008 | 0.00 |
| March 31, 2008 | 0.001M |
| December 31, 2007 | 0.034M |
| September 30, 2007 | -0.001M |
| June 30, 2007 | -0.055M |
| March 31, 2007 | 4.969M |
| December 31, 2006 | -0.071M |
| September 30, 2006 | -0.081M |
| June 30, 2006 | -5.068M |
| March 31, 2006 | -0.016M |
| December 31, 2005 | 0.01M |
| September 30, 2005 | -0.033M |
| June 30, 2005 | -0.053M |
| March 31, 2005 | -0.035M |
| December 31, 2004 | -0.005M |
| September 30, 2004 | -0.03M |
| June 30, 2004 | -0.0067M |
| March 31, 2004 | -0.0273M |
| December 31, 2003 | -0.0175M |
| September 30, 2003 | -0.0168M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Microbot Medical Inc | 0.14M |
| Alaunos Therapeutics Inc | 0.00 |
| SELLAS Life Sciences Group Inc | 0.00 |
| Oragenics Inc | 0.00 |
| Anavex Life Sciences Corp | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -8.538M |
| Cash from Financing (Quarterly) | 10.00M |
| Free Cash Flow | -33.68M |
| Free Cash Flow Per Share (Quarterly) | -0.1371 |
| Free Cash Flow Yield | -19.51% |